The molecular biology of chronic myeloid leukemia von Deininger, Michael W.N., Goldman, John M., Melo, Junia V.

Volltext

Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia von Hughes, Tim P, Kaeda, Jaspal, Branford, Susan, Rudzki, Zbigniew, Hochhaus, Andreas, Hensley, Martee L, Gathmann, Insa, Bolton, Ann E, van Hoomissen, Iris C, Goldman, John M, Radich, Jerald P

Volltext

Soluble receptor activator of nuclear factor κB ligand–osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index von Terpos, Evangelos, Szydlo, Richard, Apperley, Jane F., Hatjiharissi, Evdoxia, Politou, Marianna, Meletis, John, Viniou, Nora, Yataganas, Xenophon, Goldman, John M., Rahemtulla, Amin

Volltext

MDR1 gene overexpression confers resistance to imatinib mesylate in leukemia cell line models von Mahon, François-Xavier, Belloc, Francis, Lagarde, Valérie, Chollet, Claudine, Moreau-Gaudry, François, Reiffers, Josy, Goldman, John M., Melo, Junia V.

Volltext

Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases with Rearrangements of the Platelet-Derived Growth Factor Receptor Beta von Apperley, Jane F, Gardembas, Martine, Melo, Junia V, Russell-Jones, Robin, Bain, Barbara J, Baxter, E. Joanna, Chase, Andrew, Chessells, Judith M, Colombat, Marie, Dearden, Claire E, Dimitrijevic, Sasa, Mahon, François-X, Marin, David, Nikolova, Zariana, Olavarria, Eduardo, Silberman, Sandra, Schultheis, Beate, Cross, Nicholas C.P, Goldman, John M

Volltext

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study von Talpaz, Moshe, Silver, Richard T., Druker, Brian J., Goldman, John M., Gambacorti-Passerini, Carlo, Guilhot, Francois, Schiffer, Charles A., Fischer, Thomas, Deininger, Michael W.N., Lennard, Anne L., Hochhaus, Andreas, Ottmann, Oliver G., Gratwohl, Alois, Baccarani, Michele, Stone, Richard, Tura, Sante, Mahon, Francois-Xavier, Fernandes-Reese, Sofia, Gathmann, Insa, Capdeville, Renaud, Kantarjian, Hagop M., Sawyers, Charles L.

Volltext

Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance von Mahon, François Xavier, Deininger, Michael W. N., Schultheis, Beate, Chabrol, Jérome, Reiffers, Josy, Goldman, John M., Melo, Junia V.

Volltext

Deliberate perioperative systems design improves operating room throughput von SANDBERG, Warren S, DAILY, Bethany, EGAN, Marie, STAHL, James E, GOLDMAN, Julian M, WIKLUND, Richard A, RATTNER, David

Volltext

Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation von CROSS, N. C. P, LIN FENG, CHASE, A, BUNGEY, J, HUGHES, T. P, GOLDMAN, J. M

Volltext

Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study von Sawyers, Charles L., Hochhaus, Andreas, Feldman, Eric, Goldman, John M., Miller, Carole B., Ottmann, Oliver G., Schiffer, Charles A., Talpaz, Moshe, Guilhot, Francois, Deininger, Michael W.N., Fischer, Thomas, O'Brien, Steve G., Stone, Richard M., Gambacorti-Passerini, Carlo B., Russell, Nigel H., Reiffers, Jose J., Shea, Thomas C., Chapuis, Bernard, Coutre, Steven, Tura, Sante, Morra, Enrica, Larson, Richard A., Saven, Alan, Peschel, Christian, Gratwohl, Alois, Mandelli, Franco, Ben-Am, Monique, Gathmann, Insa, Capdeville, Renaud, Paquette, Ronald L., Druker, Brian J.

Volltext

Chronic myeloid leukemia: current treatment options von Goldman, John M., Druker, Brian J.

Volltext

Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia von BARNES, David J, PALAIOLOGOU, Danai, PANOUSOPOULOU, Eleni, SCHULTHEIS, Beate, YONG, Agnes S. M, WONG, Alice, PATTACINI, Laura, GOLDMAN, John M, MELO, Junia V

Volltext

Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia von O'Brien, Stephen G, Guilhot, François, Larson, Richard A, Gathmann, Insa, Baccarani, Michele, Cervantes, Francisco, Cornelissen, Jan J, Fischer, Thomas, Hochhaus, Andreas, Hughes, Timothy, Lechner, Klaus, Nielsen, Johan L, Rousselot, Philippe, Reiffers, Josy, Saglio, Giuseppe, Shepherd, John, Simonsson, Bengt, Gratwohl, Alois, Goldman, John M, Kantarjian, Hagop, Taylor, Kerry, Verhoef, Gregor, Bolton, Ann E, Capdeville, Renaud, Druker, Brian J

Volltext

A phase 2 study of imatinib in patients with relapsed or refractory Philadelphia chromosome–positive acute lymphoid leukemias von Ottmann, Oliver G., Druker, Brian J., Sawyers, Charles L., Goldman, John M., Reiffers, Jose, Silver, Richard T., Tura, Sante, Fischer, Thomas, Deininger, Michael W., Schiffer, Charles A., Baccarani, Michele, Gratwohl, Alois, Hochhaus, Andreas, Hoelzer, Dieter, Fernandes-Reese, Sofia, Gathmann, Insa, Capdeville, Renaud, O'Brien, Stephen G.

Volltext

A Unifying Mutation in Chronic Myeloproliferative Disorders von Goldman, John M

Volltext

Graft-Versus-Leukemia Reactions After Bone Marrow Transplantation von Horowitz, Mary M., Gale, Robert Peter, Sondel, Paul M., Goldman, John M., Kersey, John, Kolb, Hans-Jochem, Rimm, Alfred A., Ringdén, Olle, Rozman, Ciril, Speck, Bruno, Truitt, Robert L., Zwaan, Ferdinand E., Bortin, Mortimer M.

Volltext

Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia von Goldman, John M, Melo, Junia V

Volltext

The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinib von KHORASHAD, J. S, ANAND, M, KAEDA, J, MARIN, D, SAUNDERS, S, AL-JABARY, T, IQBAL, A, MARGERISON, S, MELO, J. V, GOLDMAN, J. M, APPERLEY, J. F

Volltext

Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML von Yong, Agnes S.M., Szydlo, Richard M., Goldman, John M., Apperley, Jane F., Melo, Junia V.

Volltext

Serum levels of macrophage inflammatory protein‐1 alpha (MIP‐1α) correlate with the extent of bone disease and survival in patients with multiple myeloma von Terpos, Evangelos, Politou, Marianna, Szydlo, Richard, Goldman, John M., Apperley, Jane F., Rahemtulla, Amin

Volltext